Prostate cancer screening guidelines shift; health systems must prepare
The American Cancer Society has updated its prostate cancer screening recommendations, marking a shift in how the medical community approaches the issue. According to MedPage Today, the new guidance suggests PSA blood tests every 2 years for average-risk men ages 50 through 69, and annually starting at 45 for Black men and those with a strong family history.
The change is based on longer-term research, including a European trial that followed men for 23 years. MedPage Today reported that men invited to repeated PSA screening had a 13% lower risk of dying from prostate cancer, though the absolute reduction was modest—about two fewer deaths per 1,000 men invited to screening.
However, screening also detects cancers that would never harm a man, creating trade-offs that experts weigh differently. The U.K. National Screening Committee recently declined to recommend population screening, according to MedPage Today.
MedPage Today noted that advances in diagnosis and treatment reduce complications. The outlet emphasized that informed patient agreement remains essential, and screening recommendations generally stop at age 75 or when life expectancy is under 10 years.
For health systems to support these recommendations, MedPage Today stressed the need for accessible and affordable follow-up care wherever men receive treatment.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
